ARCHIVES

“Absurd” Budget Cuts Would Devastate Cancer Program, Slash NCI Funds By $125 Million

This article is from The Cancer Letter archive.

Vol. 01 No. 44 | December 6, 1974

Download PDF Visit The Full Archive

Related Articles

Cancer Panel Urges Improved Funding For Basic Science

June 16, 1995

NCI Proposes Inviting Academic Labs To Submit New Therapies For Development

January 23, 1998

NCI Alternative to Fixed Number Of Grants Not Popular At NIH; AACR Considers New Issues Groups

July 15, 1983

Levamisole/5-FU Could Save $226 Mil. If Fully Adopted, NCI Economist Says

April 20, 1990

FDA Approval of Abraxane Sets Stage for Competition Between Taxane Drugs. Abraxane a Nanotechnology Drug? Sponsor Says Yes, FDA Says.

January 14, 2005

Study Tracks Lifestyle Factors For Cancer Burden In Blacks

October 26, 2001